Tilt Investment Management Holdings PBC Has $348,000 Stock Holdings in The Cigna Group (NYSE:CI)

Tilt Investment Management Holdings PBC reduced its position in shares of The Cigna Group (NYSE:CI) by 28.0% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 1,162 shares of the health services provider’s stock after selling 451 shares during the quarter. Tilt Investment Management Holdings PBC’s holdings in The Cigna Group were worth $348,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also added to or reduced their stakes in the company. Bogart Wealth LLC raised its holdings in shares of The Cigna Group by 104.5% in the 3rd quarter. Bogart Wealth LLC now owns 90 shares of the health services provider’s stock worth $26,000 after acquiring an additional 46 shares during the last quarter. OFI Invest Asset Management purchased a new stake in shares of The Cigna Group in the third quarter worth approximately $26,000. Fairfield Bush & CO. bought a new position in shares of The Cigna Group in the second quarter valued at approximately $28,000. Fortitude Family Office LLC purchased a new position in shares of The Cigna Group during the fourth quarter valued at approximately $29,000. Finally, Optimum Investment Advisors boosted its position in shares of The Cigna Group by 110.0% during the third quarter. Optimum Investment Advisors now owns 105 shares of the health services provider’s stock valued at $30,000 after buying an additional 55 shares during the last quarter. Institutional investors own 86.99% of the company’s stock.

The Cigna Group Price Performance

CI stock traded up $2.87 during midday trading on Thursday, reaching $348.95. The company had a trading volume of 1,050,930 shares, compared to its average volume of 1,598,389. The firm has a 50-day moving average price of $347.73 and a 200-day moving average price of $314.79. The company has a debt-to-equity ratio of 0.61, a current ratio of 0.67 and a quick ratio of 0.67. The company has a market capitalization of $102.02 billion, a P/E ratio of 19.89, a P/E/G ratio of 1.06 and a beta of 0.56. The Cigna Group has a 1 year low of $240.50 and a 1 year high of $365.71.

The Cigna Group (NYSE:CI) last released its earnings results on Friday, February 2nd. The health services provider reported $6.79 EPS for the quarter, beating analysts’ consensus estimates of $6.54 by $0.25. The Cigna Group had a return on equity of 13.59% and a net margin of 2.64%. The business had revenue of $51.15 billion for the quarter, compared to analysts’ expectations of $48.91 billion. During the same quarter in the prior year, the firm earned $4.96 earnings per share. The firm’s revenue was up 11.8% on a year-over-year basis. On average, research analysts anticipate that The Cigna Group will post 28.36 earnings per share for the current fiscal year.

The Cigna Group Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Thursday, March 21st. Shareholders of record on Wednesday, March 6th were given a dividend of $1.40 per share. This is a boost from The Cigna Group’s previous quarterly dividend of $1.23. This represents a $5.60 dividend on an annualized basis and a yield of 1.60%. The ex-dividend date of this dividend was Tuesday, March 5th. The Cigna Group’s dividend payout ratio (DPR) is presently 32.20%.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on the company. Barclays initiated coverage on The Cigna Group in a report on Wednesday, March 6th. They issued an “overweight” rating and a $393.00 target price for the company. Morgan Stanley reiterated an “overweight” rating and issued a $392.00 price objective (up previously from $382.00) on shares of The Cigna Group in a research note on Monday, March 4th. Royal Bank of Canada upgraded The Cigna Group from a “sector perform” rating to an “outperform” rating and boosted their target price for the company from $327.00 to $354.00 in a research note on Monday, February 5th. Wells Fargo & Company increased their target price on shares of The Cigna Group from $334.00 to $348.00 and gave the stock an “equal weight” rating in a research report on Tuesday, February 6th. Finally, Mizuho boosted their price target on shares of The Cigna Group from $360.00 to $370.00 and gave the company a “buy” rating in a research report on Monday, February 5th. Two equities research analysts have rated the stock with a hold rating, ten have assigned a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Buy” and a consensus target price of $362.14.

Insiders Place Their Bets

In other The Cigna Group news, CEO David Cordani sold 31,209 shares of the company’s stock in a transaction dated Monday, March 25th. The shares were sold at an average price of $355.17, for a total transaction of $11,084,500.53. Following the completion of the sale, the chief executive officer now directly owns 348,054 shares in the company, valued at $123,618,339.18. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. In related news, SVP Hoeltzel Mary T. Agoglia sold 4,867 shares of the company’s stock in a transaction on Wednesday, February 7th. The shares were sold at an average price of $330.48, for a total transaction of $1,608,446.16. Following the completion of the sale, the senior vice president now directly owns 2,102 shares in the company, valued at approximately $694,668.96. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO David Cordani sold 31,209 shares of the business’s stock in a transaction dated Monday, March 25th. The shares were sold at an average price of $355.17, for a total transaction of $11,084,500.53. Following the completion of the transaction, the chief executive officer now owns 348,054 shares in the company, valued at approximately $123,618,339.18. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 114,144 shares of company stock valued at $39,296,330. 0.60% of the stock is currently owned by corporate insiders.

About The Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.